193 related articles for article (PubMed ID: 9886850)
1. c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity.
Camp HS; Tafuri SR; Leff T
Endocrinology; 1999 Jan; 140(1):392-7. PubMed ID: 9886850
[TBL] [Abstract][Full Text] [Related]
2. p38/RK is essential for stress-induced nuclear responses: JNK/SAPKs and c-Jun/ATF-2 phosphorylation are insufficient.
Hazzalin CA; Cano E; Cuenda A; Barratt MJ; Cohen P; Mahadevan LC
Curr Biol; 1996 Aug; 6(8):1028-31. PubMed ID: 8805335
[TBL] [Abstract][Full Text] [Related]
3. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase.
Camp HS; Tafuri SR
J Biol Chem; 1997 Apr; 272(16):10811-6. PubMed ID: 9099735
[TBL] [Abstract][Full Text] [Related]
4. The hinge-helix 1 region of peroxisome proliferator-activated receptor gamma1 (PPARgamma1) mediates interaction with extracellular signal-regulated kinase 5 and PPARgamma1 transcriptional activation: involvement in flow-induced PPARgamma activation in endothelial cells.
Akaike M; Che W; Marmarosh NL; Ohta S; Osawa M; Ding B; Berk BC; Yan C; Abe J
Mol Cell Biol; 2004 Oct; 24(19):8691-704. PubMed ID: 15367687
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
Grau R; Iñiguez MA; Fresno M
Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1.
Asada S; Daitoku H; Matsuzaki H; Saito T; Sudo T; Mukai H; Iwashita S; Kako K; Kishi T; Kasuya Y; Fukamizu A
Cell Signal; 2007 Mar; 19(3):519-27. PubMed ID: 17113751
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
[TBL] [Abstract][Full Text] [Related]
8. Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1.
Lim CP; Jain N; Cao X
Oncogene; 1998 Jun; 16(22):2915-26. PubMed ID: 9671412
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptor gamma1 expression is diminished in human osteoarthritic cartilage and is downregulated by interleukin-1beta in articular chondrocytes.
Afif H; Benderdour M; Mfuna-Endam L; Martel-Pelletier J; Pelletier JP; Duval N; Fahmi H
Arthritis Res Ther; 2007; 9(2):R31. PubMed ID: 17386086
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-alpha inhibits peroxisome proliferator-activated receptor gamma activity at a posttranslational level in hepatic stellate cells.
Sung CK; She H; Xiong S; Tsukamoto H
Am J Physiol Gastrointest Liver Physiol; 2004 May; 286(5):G722-9. PubMed ID: 14656714
[TBL] [Abstract][Full Text] [Related]
11. c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for mitoxantrone- and anisomycin-induced apoptosis in HL-60 cells.
Stadheim TA; Kucera GL
Leuk Res; 2002 Jan; 26(1):55-65. PubMed ID: 11734304
[TBL] [Abstract][Full Text] [Related]
12. Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and -insensitive pathways.
Knebel A; Haydon CE; Morrice N; Cohen P
Biochem J; 2002 Oct; 367(Pt 2):525-32. PubMed ID: 12171600
[TBL] [Abstract][Full Text] [Related]
13. Transient activation of Jun N-terminal kinases and protection from apoptosis by the insulin-like growth factor I receptor can be suppressed by dicumarol.
Krause D; Lyons A; Fennelly C; O'Connor R
J Biol Chem; 2001 Jun; 276(22):19244-52. PubMed ID: 11278392
[TBL] [Abstract][Full Text] [Related]
14. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt.
Han YH; Cao X; Lin B; Lin F; Kolluri SK; Stebbins J; Reed JC; Dawson MI; Zhang XK
Oncogene; 2006 May; 25(21):2974-86. PubMed ID: 16434970
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site.
Adams M; Reginato MJ; Shao D; Lazar MA; Chatterjee VK
J Biol Chem; 1997 Feb; 272(8):5128-32. PubMed ID: 9030579
[TBL] [Abstract][Full Text] [Related]
17. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma.
Zhang B; Berger J; Zhou G; Elbrecht A; Biswas S; White-Carrington S; Szalkowski D; Moller DE
J Biol Chem; 1996 Dec; 271(50):31771-4. PubMed ID: 8943212
[TBL] [Abstract][Full Text] [Related]
18. Effects of ras transformation on the induction of the IL-1 receptor related T1 gene in response to mitogens, anisomycin, IL-1 and TNFalpha.
Laursen NB; Kessler R; Fröhli E; Klemenz R
Oncogene; 1998 Feb; 16(5):575-86. PubMed ID: 9482103
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid activation of the ERK pathway is required for embryonic stem cell commitment into the adipocyte lineage.
Bost F; Caron L; Marchetti I; Dani C; Le Marchand-Brustel Y; Binétruy B
Biochem J; 2002 Feb; 361(Pt 3):621-7. PubMed ID: 11802792
[TBL] [Abstract][Full Text] [Related]
20. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]